F-star Therapeutics to Present at The Society for Immunotherapy of Cancer (SITC) 2021 Conference
12 nov. 2021 08h00 HE
|
F-star Therapeutics, Inc.
Dr. Michelle Morrow to present on F-star’s Proprietary Bispecific Platform including FS118, our LAG-3/PD-L1 Bispecific Poster Presentation of Preclinical Data Demonstrates Potential for F-star’s...